Variable gene expression and parasite load predict treatment outcome in cutaneous leishmaniasis
Open Access
- 20 November 2019
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 11 (519)
Abstract
Patients infected with Leishmania braziliensis develop chronic lesions that often fail to respond to treatment with antiparasite drugs. To determine whether genes whose expression is highly variable in lesions between patients might influence disease outcome, we obtained biopsies of lesions from patients before treatment with pentavalent antimony and performed transcriptomic profiling on these clinical samples. We identified genes that were highly variably expressed between patients, and the variable expression of these genes correlated with treatment outcome. Among the most variable genes in all the patients were components of the cytolytic pathway, and the expression of these genes correlated with parasite load in the skin. We demonstrated that treatment failure was linked to the cytolytic pathway activated during infection. Using a host-pathogen marker profile of as few as three genes, we showed that eventual treatment outcome could be predicted before the start of treatment in two separate cohorts of patients with cutaneous leishmaniasis (n = 21 and n = 25). These findings raise the possibility of point-of-care diagnostic screening to identify patients at high risk of treatment failure and provide a rationale for a precision medicine approach to drug selection in cutaneous leishmaniasis. This work more broadly demonstrates the value of identifying genes of high variability in other diseases to better understand and predict diverse clinical outcomes.Keywords
Funding Information
- International Collaborations in Infectious Disease Research (U01 AI088650)
- Tropical Medicine Research Center (P50 AI030639)
- Center for Host-Microbial Interactions
This publication has 54 references indexed in Scilit:
- CD8+ Granzyme B+–Mediated Tissue Injury vs. CD4+IFNγ+–Mediated Parasite Killing in Human Cutaneous LeishmaniasisJournal of Investigative Dermatology, 2013
- Disease Severity in Patients Infected with Leishmania mexicana Relates to IL-1βPLOS Neglected Tropical Diseases, 2012
- Densely Interconnected Transcriptional Circuits Control Cell States in Human HematopoiesisCell, 2011
- An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosisNature, 2010
- The antiviral factor APOBEC3G improves CTL recognition of cultured HIV-infected T cellsJournal of Experimental Medicine, 2009
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression dataBioinformatics, 2009
- Recruitment of CD8+ T cells expressing granzyme A is associated with lesion progression in human cutaneous leishmaniasisParasite Immunology, 2009
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesNature Protocols, 2008
- Role of Interleukin-1β in Activating the CD11chighCD45RB−Dendritic Cell Subset and PrimingLeishmania amazonensis- Specific CD4+T Cells In Vitro and In VivoInfection and Immunity, 2007
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005